Review



pna-lna pcr clamp method  (LSI Medience Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    LSI Medience Corporation pna-lna pcr clamp method
    Pna Lna Pcr Clamp Method, supplied by LSI Medience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp/pmc10797396-83-29-33
    Average 90 stars, based on 1 article reviews
    pna-lna pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method.
    Article Snippet: EGFR mutations, G719X, exon 19 deletion, T790M, L858R and L861Q were analyzed in the central laboratory, LSI Medience Corporation (Kyoto, Japan) using the PNA-LNA clamp method.



    Similar Products

    pna-lna pcr clamp method  (srl inc)
    90
    srl inc pna-lna pcr clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Pna Lna Pcr Clamp Method, supplied by srl inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp+method/pmc11144292-71-18-28
    Average 90 stars, based on 1 article reviews
    pna-lna pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    egfr mutation testing pna-lna pcr clamp method  (srl inc)
    90
    srl inc egfr mutation testing pna-lna pcr clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Egfr Mutation Testing Pna Lna Pcr Clamp Method, supplied by srl inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/cobas+egfr+mutation+test+v2/pm38476004-49-15-28
    Average 90 stars, based on 1 article reviews
    egfr mutation testing pna-lna pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pna-lna pcr clamp method  (LSI Medience Corporation)
    90
    LSI Medience Corporation pna-lna pcr clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Pna Lna Pcr Clamp Method, supplied by LSI Medience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp/pmc10797396-83-29-33
    Average 90 stars, based on 1 article reviews
    pna-lna pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pna-lna pcr clamp method  (Medience Co Ltd)
    90
    Medience Co Ltd pna-lna pcr clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Pna Lna Pcr Clamp Method, supplied by Medience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp/pm37004157-40-7-13
    Average 90 stars, based on 1 article reviews
    pna-lna pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pna-lna polymerase chain reaction (pcr) clamp method  (LSI Medience Corporation)
    90
    LSI Medience Corporation pna-lna polymerase chain reaction (pcr) clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Pna Lna Polymerase Chain Reaction (Pcr) Clamp Method, supplied by LSI Medience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp/pmc08732858-85-18-25
    Average 90 stars, based on 1 article reviews
    pna-lna polymerase chain reaction (pcr) clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    peptide nucleic acid–locked nucleic acid (pna-lna) pcr clamp method  (LSI Medience Corporation)
    90
    LSI Medience Corporation peptide nucleic acid–locked nucleic acid (pna-lna) pcr clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Peptide Nucleic Acid–Locked Nucleic Acid (Pna Lna) Pcr Clamp Method, supplied by LSI Medience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/peptide+nucleic+acid+locked+nucleic+acid+polymerase+chain+reaction+clamp+method/pmc07334809-100-19-31
    Average 90 stars, based on 1 article reviews
    peptide nucleic acid–locked nucleic acid (pna-lna) pcr clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pna-lna clamp method  (Medience Co Ltd)
    90
    Medience Co Ltd pna-lna clamp method
    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing <t>(PNA-LNA</t> <t>PCR</t> Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).
    Pna Lna Clamp Method, supplied by Medience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pna-lna+clamp+method/pna+lna+pcr+clamp/pm31494653-30-18-22
    Average 90 stars, based on 1 article reviews
    pna-lna clamp method - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing (PNA-LNA PCR Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).

    Journal: Japanese Journal of Clinical Oncology

    Article Title: High-efficiency EGFR genotyping using cell-free DNA in bronchial washing fluid

    doi: 10.1093/jjco/hyae021

    Figure Lengend Snippet: (a). Specimen collection. Among lung carcinoma patients treated at the University of Tsukuba Hospital (Ibaraki, Japan) between 2015 and 2019, sBWF samples were obtained from 1159, and EGFR mutation testing (PNA-LNA PCR Clamp Method or Cobas EGFR Mutation Test v2) was undertaken for 310 using tissue samples (biopsy or surgical specimens). From among these cases, 80 were selected. Among them, the ex21 L858R EGFR point mutation was detected in 26 cases and the ex19 E746-A750 deletion mutation in 24; EGFR mutations were undetectable in 30 cases. Blood serum samples were included in three, three, and two cases, respectively. (b) Comparison of EGFR genotyping using cfDNA from supernatant of bronchial washing fluid (sBWF) with that using tissue samples (biopsy or surgical specimens). The positivity rate for EGFR mutation using cfDNA extracted from sBWF was 80% (40/50, ex21 L858R in 20/26 cases and ex19 E746-A750 del in 20/24 cases). Thirty cases were negative for EGFR mutation, but one case showed >2 copies of EGFR mutation/μL (ex21 L858R).

    Article Snippet: Tissue samples were fixed with 10% neutral buffered formalin and used for histological diagnosis and EGFR mutation testing (PNA-LNA PCR Clamp Method or Cobas EGFR Mutation Test v2) (SRL Inc, Tokyo, Japan).

    Techniques: Mutagenesis, Comparison

    Comparison of various EGFR analysis methods using BWF

    Journal: Japanese Journal of Clinical Oncology

    Article Title: High-efficiency EGFR genotyping using cell-free DNA in bronchial washing fluid

    doi: 10.1093/jjco/hyae021

    Figure Lengend Snippet: Comparison of various EGFR analysis methods using BWF

    Article Snippet: Tissue samples were fixed with 10% neutral buffered formalin and used for histological diagnosis and EGFR mutation testing (PNA-LNA PCR Clamp Method or Cobas EGFR Mutation Test v2) (SRL Inc, Tokyo, Japan).

    Techniques: Comparison, Real-time Polymerase Chain Reaction